192945-49-6 Usage
Uses
Used in Organic Synthesis:
4-(1H)INDAZOLE CARBOXYLIC ACID METHYL ESTER is used as a reagent or precursor for the preparation of various indazole derivatives. Its unique structure allows for the synthesis of a wide range of compounds with potential applications in various industries.
Used in Pharmaceutical Applications:
4-(1H)INDAZOLE CARBOXYLIC ACID METHYL ESTER is used as a potential candidate in the development of new drugs with therapeutic properties. Its unique chemical structure and reactivity make it a promising candidate for the creation of novel pharmaceutical compounds.
Used in Medicinal Chemistry:
4-(1H)INDAZOLE CARBOXYLIC ACID METHYL ESTER is used as an intermediate in the synthesis of bioactive compounds. Its role in medicinal chemistry is significant, as it can contribute to the development of new drugs with improved efficacy and reduced side effects.
Used in Research and Development:
4-(1H)INDAZOLE CARBOXYLIC ACID METHYL ESTER is used in research and development for the investigation of its potential applications and properties. Its unique characteristics make it an interesting subject for scientific studies, which can lead to the discovery of new uses and applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 192945-49-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,2,9,4 and 5 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 192945-49:
(8*1)+(7*9)+(6*2)+(5*9)+(4*4)+(3*5)+(2*4)+(1*9)=176
176 % 10 = 6
So 192945-49-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H8N2O2/c1-13-9(12)6-3-2-4-8-7(6)5-10-11-8/h2-5H,1H3,(H,10,11)
192945-49-6Relevant articles and documents
INDAZOLE AND PYRAZOLOPYRIDINE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS
-
Page/Page column 42-43, (2011/05/06)
Diclosed are CCRl receptor antagonists of the formula (I), wherein X is nitrogen or, C-R2; Ar1 is carbocycle, heteroaryl or heterocyclyl each optionally substituted by one to three Ra; Ar2 is carbocycle, heteroaryl or heterocyclyl, each optionally substituted by one to three Rb; Cyclic G is carbocycle, or heterocyclyl each optionally substituted by one to two R8; R1 is hydrogen, C1-6 alkyl or C 1-6 alkoxyC1-6 alkyl. Also disclosed are compositions, methods of making and using compounds of the formula (I).
INDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS
-
Page/Page column 50, (2009/12/05)
Disclosed indazoles compounds that are useful as antagonists of CCR1 activity and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Also disclosed are pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE
-
Page/Page column 127-128, (2010/11/27)
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted dihydropyridines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of C5a receptors.
